One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medications.
Sign Up to like & getrecommendations! Published in 2023 at "Neurourology and urodynamics"
DOI: 10.1002/nau.25221
Abstract: INTRODUCTION AND HYPOTHESIS Patients with overactive bladder (OAB) often undergo prolonged treatment with one or more oral OAB medications. OnabotulinumtoxinA (onabotA), a type A botulinum toxin, may provide an appropriate alternative to oral treatments in… read more here.
Keywords: one oral; refractory one; treatment history; oral medications ... See more keywords